Menu
GWAS Study

Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.

Sherva R, Tripodis Y, Bennett DA et al.

23535033 PubMed ID
GWAS Study Type
303 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

SR
Sherva R
TY
Tripodis Y
BD
Bennett DA
CL
Chibnik LB
CP
Crane PK
DJ
de Jager PL
FL
Farrer LA
SA
Saykin AJ
SJ
Shulman JM
NA
Naj A
GR
Green RC
Chapter II

Abstract

Summary of the research findings

Substantial interindividual variability exists in the disease trajectories of Alzheimer's disease (AD) patients. Some decline rapidly whereas others decline slowly, and there are no known explanations for this variability. We describe the first genome-wide association study to examine rate of cognitive decline in a sample of AD patients with longitudinal measures of cognition.

303 European ancestry cases

Chapter III

Study Statistics

Key metrics and study information

303
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
U.S., Canada
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.